Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alkermes
Alkermes
Amylin's Agreement with Lilly Will Not Lead It To Profitablity
Seeking Alpha
Mon, 11/21/11 - 06:29 pm
Eli Lilly
Amylin
GSK
Merck
Alkermes
Byetta
Novo Nordisk
Healthcare Sector: Noteworthy Insider Buys And Sells
Seeking Alpha
Tue, 11/8/11 - 11:03 am
Alkermes
Bristol-Myers Squibb
Celgene
Gilead
Illumina
Inhibitex
JNJ
United Health
Seattle Genetics
Pharmasset
Jefferies analyst upgrades Alkermes to 'buy' after completion of acquisition, move to Ireland
Yahoo/AP
Mon, 09/26/11 - 11:03 am
Alkermes
M&A
drug delivery
Elan
Lilly, Amylin, Merck Diabetes Drug Risks Highlighted
Minyanville
Tue, 09/13/11 - 02:18 pm
Merck
Eli Lilly
Amylin
diabetes
Bydureon
Alkermes
Victoza
Byetta
Novo Nordisk
Bydureon FDA Action Date Set for January 28, 2012
Pipeline Review
Sat, 08/13/11 - 04:20 pm
Bydureon
Eli Lilly
Alkermes
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Amylin, Eli Lilly & Alkermes submit reply to US FDA on Bydureon
Pharmabiz
Sat, 07/30/11 - 12:31 pm
Eli Lilly
Amylin
Alkermes
Bydureon
diabetes
Alkermes Sees 2012 Revenue Up to $480 Million on Elan Deal
Bloomberg
Mon, 07/18/11 - 05:35 pm
Elan
Alkermes
earnings
Amylin to Resubmit Diabetes Treatment to F.D.A.
NY Times
Sun, 07/10/11 - 11:28 am
Amylin
Bydureon
diabetes
Eli Lilly
Alkermes
Exenatide tQT Study Showed No Prolongation of QT Interval
Pipeline Review
Sun, 07/10/11 - 11:30 am
exenatide
Eli Lilly
diabetes
Byetta
Amylin
Alkermes
Bydureon
Let's Just Hope For No More FDA Surprises
Motley Fool
Sat, 07/9/11 - 12:39 pm
FDA
Amylin
Eli Lilly
Alkermes
Novo Nordisk
Amylin, Alkermes say diabetes drug safe for heart
Yahoo/AP
Thu, 07/7/11 - 10:13 pm
diabetes
Amylin
Alkermes
Bydureon
Biotech Clinical Trials Update: CRIS, ALKS, CHTP
Seeking Alpha
Wed, 06/22/11 - 08:14 am
clinical trials
ALKS 5461
depression
Alkermes
Northera
Chelsea Therapeutics
Multimeric-001
flu vaccine
EU approves Lilly's weekly diabetes drug Bydureon
Yahoo/AP
Tue, 06/21/11 - 10:42 am
Europe
Eli Lilly
diabetes
Bydureon
Amylin
Alkermes
It May Be Time for Amylin and Lilly to Head to Divorce Court
Seeking Alpha
Fri, 05/27/11 - 10:50 am
Eli Lilly
Amylin
restraining order
Alkermes
Bristol-Myers Squibb
Elan
GSK
JNJ
Lexicon Pharmaceuticals
Novo Nordisk
Takeda
Elan move makes it a sitting duck for big boys
Independent, Ireland
Mon, 05/16/11 - 09:30 am
Elan
M&A
Alkermes
JNJ
Alkermes to Buy Elan Drug Technology Unit for $960 Million
Bloomberg
Mon, 05/9/11 - 09:14 am
Elan
M&A
Alkermes
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug
Motley Fool
Sat, 04/16/11 - 12:20 pm
Amylin
Alkermes
diabetes
Eli Lilly
Bydureon
Positive Data on Risperdal Consta
Yahoo/Zacks.com
Wed, 03/30/11 - 09:42 am
Alkermes
Risperdal Consta
schizophrenia
JNJ
Pipeline at Alkermes Advances
Yahoo/Zacks.com
Thu, 02/17/11 - 07:56 am
Alkermes
Amylin
JNJ
ALKS 37
opiod-induced constipation
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »